Novo revamps its direct-to-consumer platform; Roche drug Gazyva approved again
Plus news about Uniquity Bio, Commit Biologics, Rosemont Pharmaceuticals, Aytu and Aclaris Therapeutics. Novo relaunches NovoCare direct-to-consumer platform: Novo is revamping its DTC business with what it calls a "reimagined consumer ...
comments(0)
5-min edit window · permanent after that